Sector Gamma AS’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.7M | Sell |
169,468
-15,509
| -8% | -$1.22M | 3% | 12 |
|
|
2025
Q4 | $14.6M | Sell |
184,977
-85,986
| -32% | -$6.47M | 3.34% | 10 |
|
|
2025
Q3 | $17.7M | Sell |
270,963
-14,879
| -5% | -$726K | 4.4% | 6 |
|
|
2025
Q2 | $11.3M | Hold |
285,842
| – | – | 3.69% | 9 |
|
|
2025
Q1 | $8.62M | Buy |
285,842
+50,000
| +21% | +$1.64M | 2.76% | 17 |
|
|
2024
Q4 | $8.25M | Buy |
235,842
+25,000
| +12% | +$934K | 2.83% | 16 |
|
|
2024
Q3 | $8.45M | Buy |
210,842
+40,842
| +24% | +$1.9M | 2.56% | 16 |
|
|
2024
Q2 | $8.1M | Sell |
170,000
-5,507
| -3% | -$226K | 3.03% | 14 |
|
|
2024
Q1 | $7.61M | Buy |
175,507
+30,495
| +21% | +$1.45M | 2.14% | 18 |
|
|
2023
Q4 | $7.34M | Sell |
145,012
-20,604
| -12% | -$987K | 1.78% | 22 |
|
|
2023
Q3 | $7.51M | Buy |
165,616
+5,215
| +3% | +$215K | 1.92% | 19 |
|
|
2023
Q2 | $6.58M | Buy |
160,401
+13,960
| +10% | +$536K | 1.47% | 20 |
|
|
2023
Q1 | $5.23M | Buy |
146,441
+5,068
| +4% | +$190K | 1.27% | 25 |
|
|
2022
Q4 | $5.34M | Sell |
141,373
-22,850
| -14% | -$961K | 1.22% | 24 |
|
|
2022
Q3 | $7.26M | Sell |
164,223
-1,216
| -0.7% | -$51.2K | 1.87% | 19 |
|
|
2022
Q2 | $6.13M | Sell |
165,439
-23,000
| -12% | -$867K | 1.37% | 22 |
|
|
2022
Q1 | $6.98M | Sell |
188,439
-21,098
| -10% | -$691K | 1.52% | 22 |
|
|
2021
Q4 | $6.38M | Sell |
209,537
-54,333
| -21% | -$1.71M | 1.5% | 25 |
|
|
2021
Q3 | $8.85M | Buy |
263,870
+382
| +0.1% | +$14.4K | 1.77% | 22 |
|
|
2021
Q2 | $10.5M | Sell |
263,488
-190,662
| -42% | -$7.47M | 1.86% | 21 |
|
|
2021
Q1 | $20.4M | Buy |
454,150
+133,158
| +41% | +$7.43M | 3.74% | 10 |
|
|
2020
Q4 | $18.1M | Buy |
320,992
+84,650
| +36% | +$4.22M | 3.45% | 11 |
|
|
2020
Q3 | $11.2M | Buy |
236,342
+46,361
| +24% | +$2.58M | 2.55% | 19 |
|
|
2020
Q2 | $11.2M | Sell |
189,981
-85,500
| -31% | -$4.76M | 2.31% | 20 |
|
|
2020
Q1 | $13M | Buy |
275,481
+57,846
| +27% | +$3.22M | 2.78% | 17 |
|
|
2019
Q4 | $13.1M | Buy |
217,635
+86,121
| +65% | +$5.13M | 2.11% | 20 |
|
|
2019
Q3 | $7.88M | Hold |
131,514
| – | – | 1.33% | 27 |
|
|
2019
Q2 | $8.45M | Sell |
131,514
-102,200
| -44% | -$7.22M | 1.36% | 24 |
|
|
2019
Q1 | $19M | Sell |
233,714
-145,707
| -38% | -$9.4M | 3.04% | 13 |
|
|
2018
Q4 | $20.5M | Buy |
379,421
+176,987
| +87% | +$9.03M | 3.45% | 13 |
|
|
2018
Q3 | $10.4M | Sell |
202,434
-100,806
| -33% | -$4.74M | 1.64% | 19 |
|
|
2018
Q2 | $12.6M | Buy |
303,240
+29,740
| +11% | +$1.32M | 2.1% | 16 |
|
|
2018
Q1 | $12.1M | Buy |
273,500
+211,400
| +340% | +$10.7M | 2.17% | 18 |
|
|
2017
Q4 | $3.12M | Buy |
+62,100
| New | +$3.41M | 0.53% | 31 |
|
Other funds holding IONS
VPM
VCM
Sector Gamma AS's IONS Position: Q1 2026 in Review
Sector Gamma AS reduced its Ionis Pharmaceuticals (IONS) stake by 8.4% in Q1 2026, selling an estimated $1.22M and leaving 169,468 shares worth $12.7M. The position accounts for 3% of the portfolio, ranked #12.
Sector Gamma AS first reported a position in IONS in Q4 2017 and has held it in 34 quarters since. The position peaked at $20.5M in Q4 2018. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- Sector Gamma AS held 169,468 shares of Ionis Pharmaceuticals worth $12.7M as of Q1 2026.
- Sector Gamma AS sold 15,509 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.22M.
- Ionis Pharmaceuticals made up 3% of Sector Gamma AS's portfolio in Q1 2026, its #12 holding.
- Sector Gamma AS first reported a position in Ionis Pharmaceuticals in Q4 2017 and has held it in 34 quarters since.
- Sector Gamma AS's Ionis Pharmaceuticals position peaked at $20.5M in Q4 2018.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on Sector Gamma AS's 13F filing for Q1 2026, filed 7 May 2026.